Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomised, Open-Label, Single-Centre, Crossover Study in Healthy Male Volunteers to Assess the Effect of Food on the Pharmacokinetics of a 10 mg Single Oral Dose of ZD4054

Next Previous
Search
Trial Profile

A Randomised, Open-Label, Single-Centre, Crossover Study in Healthy Male Volunteers to Assess the Effect of Food on the Pharmacokinetics of a 10 mg Single Oral Dose of ZD4054

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 03 Dec 2010

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Zibotentan (Primary)
  • Indications Non-small cell lung cancer; Prostate cancer
  • Focus Pharmacokinetics
  • Sponsors AstraZeneca

Most Recent Events

  • 12 Nov 2008 Status changed from active, no longer recruiting to completed.
  • 04 Aug 2008 Status changed from recruiting to in progress, as reported by ClinicalTrials.gov.
  • 29 Jul 2008 New trial record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top